China Pharma Holdings, Inc. (CPHI) vs Zhengye Biotechnology Holding Limited (ZYBT)
- China Pharma Holdings, Inc. CPHI 0.71 −2.74%
- Zhengye Biotechnology Holding Limited ZYBT 1.43 −4.67%
China Pharma Holdings, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $44.6M against $31.3M — 1.4× the size. Across the 9 metrics below, Zhengye Biotechnology Holding Limited leads on 6 and China Pharma Holdings, Inc. on 3.
Valuation
Profitability
| Metric | CPHI | ZYBT | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.76% | — | 53.94% |
| Operating margin | (111.84%) | — | 0.00% |
| Net margin | (114.33%) | — | 0.00% |
| Free cash flow margin | (3.59%) | 0.00% | 0.00% |
| Return on equity | (20.99%) | 0.00% | (0.40%) |
| Return on assets | (15.30%) | 0.00% | (3.32%) |
| Return on invested capital | (7.23%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack